Publications by authors named "Alexander D Heini"

Claim this Profile
P
Peeling Back the Layers: Recurrent Talquetamab Skin Toxicity after Supportive Stem Cell Boost in Multiple Myeloma.
Alexander D Heini, Vera Ulrike Bacher, Dilara Akhoundova, Katja Seipel, Thomas Pabst

Acta Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender-Specific Prognostic Impact of Treosulfan Levels in High-Dose Chemotherapy for Multiple Myeloma.
Alexander D Heini, Karin Kammermann, Ulrike Bacher, Barbara Jeker, Michael Hayoz

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL).
Alexander D Heini, Ulrike Bacher, Thomas Pabst

Br J Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia.
Alexander D Heini, Philipp Beck, Ulrike Bacher, Katja Seipel, Thilo Zander

J Clin Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma.
Alexander D Heini, Ulrike Bacher, Naomi Porret, Gertrud Wiedemann, Myriam Legros

Cells· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center.
Alexander D Heini, Ulrike Bacher, Marie-Noëlle Kronig, Gertrud Wiedemann, Urban Novak

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML.
Alexander D Heini, Naomi Porret, Reinhard Zenhaeusern, Annette Winkler, Ulrike Bacher

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia.
Alexander D Heini, Rebecca Hugo, Martin D Berger, Urban Novak, Ulrike Bacher

Hematol Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
Martin D Berger, Alexander D Heini, Katja Seipel, Beatrice Mueller, Anne Angelillo-Scherrer

Hematol Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years.
Alexander D Heini, Martin D Berger, Katja Seipel, Behrouz Mansouri Taleghani, Gabriela M Baerlocher

Leuk Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis